Alere relaunches Determine disease detection product range

Alere has announced the rebranding and relaunch of the Determine diagnostic product range in a move designed to strengthen its brand identity.

The diverse range of fast-acting infection testing systems have been renamed to include the Alere branding on their packaging, which will support the firm's continuing transition from its previous Inverness Medical identity.

Among the products in the Determine line are testing kits for HIV, hepatitis, Aids and syphilis, with results being generated by the products in around 15 to 20 minutes.

Rights to the product portfolio were purchased from Abbott back in 2005.

Tom Lindsay, a business development manager at Alere Healthcare, said: "With our new brand image we aim to make it clear to healthcare professionals that we hold many of the quality tools they need."

The firm adopted its new Alere brand identity last year, with the name encompassing the operations of 18 diagnostics and health management companies.